We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis.
- Authors
Trzcinski, R.; Dziki, A.; Mik, M.; Kujawski, R.; Dziki, L.; Brys, M.; Moszynska‐Zielinska, M.; Chalubinska‐Fendler, J.
- Abstract
Abstract: Aim: The aim of this study was to assess the expression of vascular endothelial growth factor (VEGF) as a key proangiogenic factor and determine whether there is any correlation between its expression and clinical symptoms or endoscopic changes in patients with chronic radiation proctitis (ChRP). Method: Fifty patients who had all undergone radiotherapy for prostate, cervical or uterine cancer were included in the study (37 women, 13 men). There was a control group of 20 patients (9 women, 11 men). The Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) scoring system was used for grading the severity of the proctitis. Endoscopic scoring of late rectal mucosal damage was performed using Gilinsky's classification. Serum levels of VEGF were analysed by the enzyme‐linked immunosorbent assay method. Results: Most patients presented with Grade 1 symptoms. Endoscopic assessment showed that most patients had Grade 1 late rectal mucosal damage. The predominant endoscopic finding was the presence of telangiectasia. Assessment of VEGF correlation between the control group and the degrees of endoscopic changes showed statistically significant differences for all three degrees (<italic>P </italic><<italic> </italic>0.0001, <italic>P </italic>=<italic> </italic>0.0251 and <italic>P </italic>=<italic> </italic>0.0005, respectively). Due to the small numbers of patients with Grades 2 and 3 symptoms using the RTOG/EORTC scoring system, they were grouped with Grades 1 and 4 respectively forming two groups for statistical purposes. VEGF expression differed significantly between controls and group I and between controls and group II (<italic>P </italic>=<italic> </italic>0.0001, <italic>P </italic>=<italic> </italic>0.0009, respectively). Conclusion: A significant increase in VEGF expression was found to correlate with clinical symptoms and endoscopic rectal mucosa changes in patients with ChRP, suggesting that it may play an important role in pathological angiogenesis.
- Subjects
VASCULAR endothelial growth factors; PROCTITIS; RADIOTHERAPY; UTERINE cancer; ENZYME-linked immunosorbent assay; NEOVASCULARIZATION; ENDOSCOPIC surgery
- Publication
Colorectal Disease, 2018, Vol 20, Issue 4, p321
- ISSN
1462-8910
- Publication type
Article
- DOI
10.1111/codi.13902